Wow, MSB really leading the way (joke):Longeveron Granted Orphan Drug Designation by FDA for Lomecel-B to Treat Infants with Hypoplastic Left Heart Syndrome (HLHS)
December 6, 2021
- HLHS is a rare congenital heart defect that affects approximately 1,000 babies in the U.S. per year
- Orphan Drug Designation confers certain benefits and may result in seven year market exclusivity upon approval for this indication if all statutory and regulatory requirements are met
- Supplements Rare Pediatric Disease Designation recently granted by FDA
MIAMI, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and certain life-threatening conditions, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome (HLHS), a rare and life-threatening congenital heart defect in infants.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-76
-
-
- There are more pages in this discussion • 305 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
90.0¢ |
Change
-0.015(1.64%) |
Mkt cap ! $1.021B |
Open | High | Low | Value | Volume |
90.5¢ | 90.5¢ | 89.5¢ | $1.526M | 1.700M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 47306 | 90.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
90.5¢ | 74801 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 49769 | 0.900 |
13 | 199602 | 0.895 |
23 | 219719 | 0.890 |
11 | 296614 | 0.885 |
14 | 246532 | 0.880 |
Price($) | Vol. | No. |
---|---|---|
0.905 | 71032 | 20 |
0.910 | 70396 | 8 |
0.915 | 87234 | 8 |
0.920 | 56407 | 5 |
0.925 | 47070 | 3 |
Last trade - 11.24am 08/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |